Recent news on Solaraze

Bradley Pharmaceuticals 2007 First Quarter Results  -  May 10, 2007
PR Newswire (press release),The increase in our net sales for the quarter ended March 31, 2007 was primarily led by the actinic keratosis product SOLARAZE(R) (diclofenac sodium- 3%)

Bradley Pharmaceuticals 2006 Results  -  Mar 28, 2007
Drug Newswire (press release),The increase in our net sales for 2006 was primarily led by the actinic keratosis product SOLARAZE(R) (diclofenac sodium-3%) and the authorized generics of

Bradley Pharmaceuticals 2006 Results  -  Mar 14, 2007
PR-Inside.com (Pressemitteilung),The increase in our net sales for 2006 was primarily led by the actinic keratosis product SOLARAZE(R) (diclofenac sodium-3%) and the authorized generics of

Bradley Pharmaceuticals Swings to Profit  -  Mar 14, 2007
Houston Chronicle,Bradley Pharmaceutical said sales grew in 2006 on the back of its Solaraze product, which treats actinic keratosis, which helped the company overcome

Bradley Pharmaceuticals Brand Featured at 65th Annual Meeting of ...  -  Feb 5, 2007
PharmaLive.com (press release),Two hundred forty-four patients were treated with cryosurgery followed by 90 days of therapy with Solaraze(R) Gel, while 277 patients received cryosurgery

SHIRE PLC: Final Results  -  Feb 20, 2007
FinanzNachrichten.de,21.5 13.5 +59% 1% SOLARAZE 13.2 12.5 +6% 1% VANIQA 7.9 6.3 +25% - LODINE 12.6 12.6 - 1% ___________ ___________ ___________ ___________ 206.3 229.9 -10%

International Approvals: Solaraze, Nasonex, Advate  -  Dec 5, 2006
Medscape (subscription)On November 28, Australia's Therapeutic Goods Administration approved diclofenac sodium 3% gel in a 2.5% hyaluronic acid base (Solaraze, marketed by Shire

SkyePharma PLC announces Solaraze Approval  -  Nov 27, 2006
Genetic Engineering News (press release),SkyePharma's marketing partner in Australia is Shire Pharmaceuticals plc, which hopes to launch Solaraze(R) in early 2007 subject to discussions with

Australian Government TGA Approves Registration of Solaraze(R) 3 ...  -  Nov 28, 2006
netPR.pl (komunikaty prasowe),..."I am delighted with this decision and the positive assessment of Solaraze(R) 3% gel (diclofenac sodium) for the management of actinic keratosis,

Australian Government TGA Approves Registration of Solaraze(R) 3 ...  -  Nov 28, 2006
Earthtimes.orgSolaraze(R) is a topical gel consisting of 3% diclofenac in a2.5% hyaluronic acid base and is indicated for the management/treatment ofactinic keratosis.

SkyePharma says Australian Therapeutic Goods Administration ...  -  Nov 28, 2006
Forbes,Solaraze is a topical gel to treat actinic keratosis, an early stage skin cancer recently defined by the European Dermatology Forum as in-situ squamous cell

SkyePharma says Australian Therapeutic Goods Administration ...  -  Nov 28, 2006
Hemscott,The company said its marketing partner in Australia is Shire Pharmaceuticals plc, which hopes to launch Solaraze in early 2007 subject to discussions with

SkyePharma Says US FDA Approves Foradil Certihaler - Update  -  Dec 18, 2006
Trading Markets,SkyePharma expects double digit royalty payments on net sales from Solaraze, for which Shire Pharmaceuticals plc. is the marketing partner in Australia.

SkyePharma stock up as FDA approves asthma inhaler  -  Dec 19, 2006
Pharma Times (subscription),The news rounds off a good month for SkyePharma which recently announced that its actinic keratosis product, Solaraze (diclofenac) has been given approval

(PRN) - MacroChem to Present at the Equities Magazine Discovery ...  -  Nov 28, 2006
Bolsamania.com,...(PRN) - Australian Government TGA Approves Registration of Solaraze(R) 3% Gel (diclofenac sodium) for the Management of Actinic Keratosis ... [+]

Shire plc: Excellent Third Quarter With Execution Plan on Track ...  Oct 27, 2006
...hydrobromide) (UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide) (UK and Republic of Ireland) REPLAGAL(R) (agalsidase alfa) SOLARAZE(R) (3 ... -PR Newswire (press release), Diclofenac Sodium With Cryotherapy Treats Neoplastic Skin Lesion ...  Oct 10, 2006
...[Presentation title: Topical 3% Diclofenac in 2.5% Hyaluronic Acid Gel (Solaraze(TM)) Plus Cryotherapy for the Treatment of Actinic Keratosis (AK). ... -DG News Shire plc: IFRS Information - First Half of 2006  Sep 18, 2006
UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide)(UK and Republic of Ireland) REPLAGAL® (agalsidase alfa) SOLARAZE® (3% diclofenac sodium ... -Yahoo! News

Shire plc: IFRS Information - First Half of 2006  Sep 18, 2006
...hydrobromide)(UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide)(UK and Republic of Ireland) REPLAGAL(R) (agalsidase alfa) SOLARAZE(R) (3 ... -PR Newswire

Some Anti-Inflammatory Drugs Are Safer Than Others  Sep 13, 2006
...authors of the study - have requested for the "regulatory status" of diclofenac, also known under the trade names of Voltaren, Cataflam, Solaraze and Arthrotec ... -All Headline News

Cox-2 Inhibitors, NSAIDs Pose Heart and Kidney Risks  Sep 13, 2006
...reviewed. Diclofenac is marketed as a generic drug and also under the trade names Voltaren, Cataflam, Solaraze and Arthrotec. Dr ... -Food Consumer

Some anti-inflammatory drugs can increase cardiac risk  Sep 13, 2006
...a review of the regulatory status of diclofenac, which is marketed as a generic drug and also under the trade names Voltaren, Cataflam, Solaraze and Arthrotec. ... -South Asian Women's Forum

Bradley Pharmaceuticals Brands Featured in Two Scientific Poster ...  Sep 7, 2006
Summer American Academy of Dermatology meeting, held July 26 - 30, 2006 in San Diego, CA, a poster presented clinical evaluations of Solaraze® Gel (diclofenac ... -Yahoo! News

Bradley Pharmaceuticals Brands Featured in Two Scientific Poster ...  Sep 7, 2006
At the Summer American Academy of Dermatology meeting, held July 26 - 30, 2006 in San Diego, CA, a poster presented clinical evaluations of Solaraze(R) Gel ... -Business New Jersey (subscription)

International Approvals: Solaraze, Nasonex, Advate  -  Dec 5, 2006
Medscape (subscription)On November 28, Australia's Therapeutic Goods Administration approved diclofenac sodium 3% gel in a 2.5% hyaluronic acid base (Solaraze, marketed by Shire

Australian Government TGA Approves Registration of Solaraze(R) 3 ...  -  Nov 28, 2006
Drug Newswire (press release),..."I am delighted with this decision and the positive assessment of Solaraze(R) 3% gel (diclofenac sodium) for the management of actinic keratosis,

SkyePharma PLC announces Solaraze Approval  -  Nov 27, 2006
Genetic Engineering News (press release),SkyePharma's marketing partner in Australia is Shire Pharmaceuticals plc, which hopes to launch Solaraze(R) in early 2007 subject to discussions with

Australian Government TGA Approves Registration of Solaraze(R) 3 ...  -  Nov 28, 2006
Earthtimes.orgSolaraze(R) is a topical gel consisting of 3% diclofenac in a2.5% hyaluronic acid base and is indicated for the management/treatment ofactinic keratosis.

SkyePharma says Australian Therapeutic Goods Administration ...  -  Nov 28, 2006
Forbes,Solaraze is a topical gel to treat actinic keratosis, an early stage skin cancer recently defined by the European Dermatology Forum as in-situ squamous cell

SkyePharma says Australian Therapeutic Goods Administration ...  -  Nov 28, 2006
Hemscott,The company said its marketing partner in Australia is Shire Pharmaceuticals plc, which hopes to launch Solaraze in early 2007 subject to discussions with

Doctor Feelgood  -  Nov 18, 2006
Scotsman,I sometimes also prescribe Solaraze cream. Occasionally they need shaved off (curetted) under local anaesthetic. But correct treatment depends on accurate

(PRN) - MacroChem to Present at the Equities Magazine Discovery ...  -  Nov 28, 2006
Bolsamania.com,...(PRN) - Australian Government TGA Approves Registration of Solaraze(R) 3% Gel (diclofenac sodium) for the Management of Actinic Keratosis ... [+]

Shire plc: First 2006 Product Launched, Another Approved and ...  Jul 28, 2006
...hydrobromide) (UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide) (UK and Republic of Ireland) REPLAGAL(R) (agalsidase alfa) SOLARAZE(R) (3 ... -PR Newswire

The skin-cancer danger for a sunburnt scalp  Jul 13, 2006
...ravaged skin need to consult a dermatologist regularly so that any early changes may be detected and suspicious lesions treated with cautery and Solaraze gel. ... -Times Online

SkyePharma Business Review Day 2006  Jun 21, 2006
...version of Sanofi-Aventis's Xatral® (alfuzosin), a treatment for the urinary symptoms of benign prostatic hypertrophy; and Solaraze®, SkyePharma's topical ... -Yahoo! News

SkyePharma Business Review Day 2006  Jun 21, 2006
...daily version of Sanofi-Aventis's Xatral(R) (alfuzosin), a treatment for the urinary symptoms of benign prostatic hypertrophy; and Solaraze(R), SkyePharma's ... -Drug Newswire



Doctors use creams to treat some skin cancers  16 May 2006
...option," Giancola said. Aldara, Efudex and Solaraze work best on patients with widespread lesions, like Tamara Monero. "I had a ... - AZFamily (subscription)

SkyePharma PLC - Preliminary Results Announcement for the Year ...  Apr 19, 2006
OTHER PRODUCTS Solaraze(R) Solaraze(R) is our topical gel treatment for actinic keratosis and our proprietary hyaluronic acid formulation ensures that a high ... - PR Newswire

Shire Announces Good Start to the Year and Guidance Reaffirmed  Apr 27, 2006
...hydrobromide) (UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide) (UK and Republic of Ireland) REPLAGAL(R) (agalsidase alfa) SOLARAZE(R) (3 ... - PR Newswire





Professional opinion  Mar 8, 2006
...with visible success. Is this an advisable use of the drug? The overseas product you mention is called Solaraze. It contains 3 per ... - Sydney Morning Herald



Shire plc: Strong 2005 Performance Supports Positive Outlook  Feb 23, 2006
...hydrobromide) (UK and Republic of Ireland) REMINYL XL(TM) (galantamine hydrobromide) (UK and Republic of Ireland) REPLAGAL(R) (agalsidase alfa) SOLARAZE(R) (3 ... - PR Newswire,

HSD bags Solaraze med ed brief  Jan 10, 2006
Shire Pharmaceuticals has brought in HSD Communications to raise the profile of its Solaraze product among UK health professionals. ... - PRWeek (subscription)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional